Drug Discovery trainee driven to reverse negative trends in colorectal cancer.

With more and more young adults being diagnosed with colorectal cancer, Aisha Naamani wants to provide better ways to treat the disease.

Naamani is a Ph.D. student on OICR’s Drug Discovery team, supervised by Dr. Rima Al-awar. She is working to validate potential therapeutic targets for colorectal cancer, which she hopes could one day lead to new therapeutic options.

“I hope that this research adds to our general understanding of the disease,” Naamani says. “I also hope this could pave the way for translating basic research into clinical practice and benefiting patients.”

Born in Oman, Naamani also wants to help develop the field of cancer research in the Middle East.
“I’m eager to take part of that development and contribute to the scientific community,” she says.
Find out more by watching Naamani’s The Next Generation video.